TIRZEPATIDE – 10 MG

TIRZEPATIDE – 10 MG

Research Areas: GLP-1 and GIP receptor signaling, glucose metabolism, insulin secretion, and metabolic regulation.

Tirzepatide is a synthetic peptide that acts as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

Scientific research has examined its effects on glucose regulation, insulin signaling, appetite, and metabolic function.

Product Information

• Compound: Tirzepatide

• Listed Quantity: 10 mg

• Classification: Dual GIP/GLP-1 receptor agonist

• Research Focus: Metabolic and endocrine signaling

• FDA Status: Approved in specific prescription formulations

Important Notice

This product is not represented as an FDA-approved pharmaceutical formulation. The listed quantity and product specifications require supplier verification. Laboratory labeling does not establish suitability for human or animal administration.